Clinical trial

Zoladex® 10.8 BC RWS

NCT05184257

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-01-06

PhaseN/A

Study timeline

Study start (actual)2022-01-06Date precision: day

Registry last updated2025-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

GuangzhouChina2 BeijingChina1 ShanghaiChina1 TianjinChina1 ChengduChina1 HangzhouChina1 ChangshaChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05184257 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.